Order results by:
| Issue | Title | |
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). The presence of anxiety-depressive spectrum ..." | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... with citicoline (Noocil®) on cognitive function and quality of life (QoL)in patients with mild cognitive ..." | ||
| Vol 13, No 1 (2021) | Cognitive impairment in COVID-19 survivors | Abstract similar documents |
| T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov | ||
| "... of COVID-19. There are more and more publications on the presence of a complication, such as cognitive ..." | ||
| Vol 3, No 3 (2011) | Poststroke cognitive impairments and their therapy with ceraxon | Abstract similar documents |
| N. V. Shakhparonova, A. S. Kadykov, E. M. Kashina | ||
| "... Objective: to evaluate the effect of citicoline (ceraxon) on recovery of cognitive functions ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... therapies for MCI. Multiple pharmacological effects of citicoline on cognitive functions of patient ..." | ||
| Vol 7, No 3 (2015) | The heterogeneity of vascular cognitive impairments and the issues of therapy | Abstract similar documents |
| Elena Anatolyevna Katunina | ||
| "... Vascular cognitive impairments (CIs) are heterogeneous in the mechanism of their occurrence ..." | ||
| Vol 16, No 5 (2024) | Asthenia and vascular cognitive impairment in young patients after stroke | Abstract similar documents |
| L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva | ||
| "... was assessed by Montreal Cognitive Assessment (MoCA) and asthenia by manifestations of general fatigue ..." | ||
| Vol 8, No 2 (2016) | Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina, D. O. Gromova | ||
| "... cognitive impairments (CI) that are one of the important factors that negatively influence the outcome ..." | ||
| Vol 12, No 2 (2020) | The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment | Abstract similar documents |
| V. A. Golovacheva | ||
| "... indicating a cognitive defect. Citicoline is one of the most widely used nootropic drugs for cerebrovascular ..." | ||
| Vol 6, No 3 (2014) | Effect of citicoline on blood pressure variability | Abstract similar documents |
| O. D. Ostroumova, N. Yu. Taranenko | ||
| "... with hypertension and cognitive impairments. Objective: to determine the efficiency of citicoline therapy ..." | ||
| Vol 2, No 3 (2010) | Clinical experience with ceraxon used in ischemic stroke | Abstract similar documents |
| V. A. Parfenov, T. G. Fateyeva, O. V. Kosivtsova | ||
| "... Citicoline (Ceraxon) is a neuroprotective agent used in acute ischemic stroke (IS) and chronic ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... of cognitive impairment (CI) of varying severity. The main causes of CI are Alzheimer's disease (AD), vascular ..." | ||
| Vol 1, No 3-4 (2009) | CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS | Abstract similar documents |
| V. A. Parfenov | ||
| "... cognitive disorders. Experimental animal studies have demonstrated that citicolin reduces the extent ..." | ||
| Vol 14, No 4 (2022) | Effect of statins on oxidative stress and cognitive function in patients with cerebral atherosclerosis: results of a prospective cohort study | Abstract similar documents |
| K. V. Nikulina, O. V. Vorobieva, V. V. Fateeva | ||
| "... of oxidative stress using Fe2+-induced chemiluminescence and cognitive phenotype, using the MoCA test ..." | ||
| Vol 4, No 4 (2012) | Citicoline for ischemic stroke: ICTUS trial | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... The paper gives data available in the literature on the use of citicoline in an experimental model ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... properties of cyticolin and its use in cognitive impairments (CIs). It assesses trials investigating ..." | ||
| Vol 4, No 2 (2012) | Evolution of cognitive deficit: mild and moderate cognitive impairments | Abstract similar documents |
| V V Zakharov | ||
| "... neuropsychological tests, such as the Montreal Cognitive Assessment (MoCA) test should be used to diagnose non ..." | ||
| Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
| "... Objective: to investigate the effect of citicoline (CTC) on gene transcription. Material ..." | ||
| Vol 3, No 1 (2011) | Current treatments for brain contusions | Abstract similar documents |
| A. E. Talypov, S. S. Petrikov, Yu. V. Puras, A. A. Solodov, Yu. V. Titova | ||
| Vol 16, No 5 (2024) | Clinical features of vascular cognitive impairment | Abstract similar documents |
| O. O. Martynova, N. V. Vakhnina, V. V. Zakharov | ||
| "... Vascular cognitive impairment (VCI) can occur in cerebrovascular disease of varying degree ..." | ||
| Vol 15, No 1 (2023) | Efficacy of a combination of non-drug therapies in patients with non-dementia vascular cognitive impairment | Abstract similar documents |
| M. S. Novikova, V. V. Zakharov, N. V. Vakhnina | ||
| "... compared to the first visit: Montreal Cognitive Function Assessment Scale (MoCA-test) – from 22.5±2.4 to 23 ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... Cognitive Assessment (MoCA), the McNair and Kahn memory self-evaluation scale, the Hospital Anxiety ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... A common tool for detecting mild cognitive impairment (MCI) is the Montreal Cognitive Assessment ..." | ||
| Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
| I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
| "... with the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). For evaluation ..." | ||
| Vol 13, No 1 (2021) | Chronic cerebral ischemia and headache in patients in primary care physician's practice | Abstract similar documents |
| V. N. Shishkova, T. V. Adasheva | ||
| "... ) and Neupilept® (citicoline) in this category of patients. ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... ; the Benton visual retention test, the Munsterberg test; the Montreal Cognitive Assessment (MoCA), the trail ..." | ||
| Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
| E. A. Kovalenko, A. N. Bogolepova | ||
| "... of the patients was 64.18±10.24 years. The Montreal Cognitive Assessment (MoCA) was applied to assess cognitive ..." | ||
| Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
| D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
| "... (p<0.05) improvement in CF was found according the Montreal Cognitive Assessment (MoCA-test), Frontal ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Motor function recovery in patients after ischemic stroke | Abstract similar documents |
| Yu. A. Starchina | ||
| "... in post-stroke movement disorders. The use of citicoline to improve motor function recovery is discussed. ..." | ||
| Vol 16, No 1 (2024) | Treatment of cognitive impairment in patients with cerebral infarction in the internal carotid arteries circulation system: results of a multicentre, randomized, double-blind, placebo-controlled clinical trial | Abstract similar documents |
| D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova | ||
| "... points on the Montreal Cognitive Assessment, MoCA), full consciousness (15 points on the Glasgow Coma ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... with piracetam/cinnarizine and aminophenylbutyric acid in non-demented patients with vascular cognitive ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... , and emotional disturbances. The evaluation included neurological exam, Montreal Cognitive Assessment Scale (MoCA ..." | ||
| Vol 11, No 2 (2019) | Comparative study of pharmacological correction strategies for moderate cognitive impairment in hypertensive patients | Abstract similar documents |
| O. V. Vorobyeva, Zh. M. Sizova, L. M. Bogatyreva | ||
| "... of treatment, the Montreal Cognitive Assessment (MoCa) scores increased from 24.5Ѓ}0.8 to 27.5Ѓ}0.6 (p<0 ..." | ||
| Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
| D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
| "... (PDQ-39), anxiety and depression (HADS), and Beck depression inventory, assessment of cognitive ..." | ||
| Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
| O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
| "... months using Montreal Cognitive Assessment (MoCA). The study took place during COVID-19 pandemic, and 25 ..." | ||
| Vol 12, No 3 (2020) | Drug-induced cognitive impairment | Abstract similar documents |
| O. D. Ostroumova, M. I. Kulikova, T. M. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, V. A. Parfenov | ||
| "... commonly prescribed drugs, can cause cognitive impairment (CI). The negative effect of drugs on cognitive ..." | ||
| Vol 12, No 2 (2020) | Near-moderate cognitive decline | Abstract similar documents |
| N. N. Koberskaya, T. M. Ostroumova | ||
| "... Management of patients with cognitive impairment is one of the most relevant and important problems ..." | ||
| Vol 11, No 1 (2019) | The modern concept of cognitive reserve | Abstract similar documents |
| N. N. Koberskaya, G. R. Tabeeva | ||
| "... The main forms of cognitive impairment (CI) are characterized by a significant variability ..." | ||
| Vol 11, No 4 (2019) | Poststroke cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... Cognitive impairment (CI) is one of the leading causes of disability after stroke; CI is observed ..." | ||
| Vol 2, No 1 (2010) | COGNITIVE IMPAIRMENTS AFTER STROKE | Abstract similar documents |
| N. G. Katayeva, N. A. Kornetov, E. V. Karavayeva, V. A. Chistyakova, A. M. Eliseyeva | ||
| "... the pattern and degree of cognitive impairments depending on the site of a lesion. A control group comprised ..." | ||
| Vol 5, No 4 (2013) | Cognitive impairments in epilepsy | Abstract similar documents |
| Aleksandr Anatolyevich Kostylev, N V Pizova, N A Pizov | ||
| "... Cognitive impairments in epilepsy are a current problem in neurology. The basis of the idea ..." | ||
| Vol 6, No 1 (2014) | Vascular cognitive impairment | Abstract similar documents |
| N.V. Vakhnina | ||
| "... Vascular pathology of the brain is the second most common cause of cognitive impairment after ..." | ||
| Vol 5, No 2 (2013) | Post-stroke cognitive impairments | Abstract similar documents |
| Elena Anatolyevna Katunina, L P Belikova, A A Makarova | ||
| "... Post-stroke cognitive impairments are common effects of stroke. Vascular cognitive impairments ..." | ||
| Vol 3, No 2 (2011) | Stroke and cognitive disorders | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... Cognitive disorders (CDs) are diagnosed in most patients within the first months after stroke ..." | ||
| Vol 3, No 4 (2011) | Current therapy for cognitive impairments | Abstract similar documents |
| N. V. Vakhnina | ||
| "... Cognitive impairments (CIs) are a highly common type of neurological disorders particularly ..." | ||
| Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
| "... performed. The influence of cognitive impairments (CI), background and comorbidities, as well as drug ..." | ||
| Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
| S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
| "... with MiniMental State Examination, Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery. EBD ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Cognitive reserve and cognitive impairments: drug and nondrug treatments | Abstract similar documents |
| E.I. Dainikova, N.V. Pizova | ||
| "... The paper discusses concepts, such as cognitive reserve (CR) and cognitive impairments (CI ..." | ||
| Vol 16, No 6 (2024) | Pain and cognitive functions – the battle for cognitive reserve | Abstract similar documents |
| L. T. Akhmedzhanova, G. R. Tabeeva, E. V. Mandra | ||
| "... on patients' quality of life. In the process of pain chronification emotional-affective, cognitive ..." | ||
| Vol 12, No 3 (2020) | Cerebral structural and functional changes in diabetes mellitus | Abstract similar documents |
| M. V. Matveeva, Yu. G. Samoilova, N. G. Zhukova, I. V. Tolmachev, E. E. Ermak, O. S. Tonkih | ||
| "... . The Montreal Cognitive Assessment (MoCA test) was used to evaluate CI. Glycemia and its variability ..." | ||
| Vol 15, No 2 (2023) | Antioxidant therapy in the complex treatment of patients with ischemic stroke in the acute and recovery period | Abstract similar documents |
| Yu. A. Belova, S. V. Kotov | ||
| "... according to the Montreal Cognitive Scale (MoCA), and an increase in the MoCA score by 2 points or more ..." | ||
| Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... The management of patients with cognitive impairment (CI) is one of the urgent problems of modern ..." | ||
| Vol 13, No 1 (2021) | Cognitive impairment in hypertension | Abstract similar documents |
| Yu. A. Starchina, V. V. Zakharov | ||
| "... As the life expectancy of the population increases, cognitive impairment (CI) caused ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular depression and cognitive dysfunction | Abstract similar documents |
| A. N. Bogolepova | ||
| "... сосудистой депрессии являются наличие когнитивных нарушений и повышение риска развития деменции. ..." | ||
| Vol 11, No 1 (2019) | Cognitive impairment in primary hyperparathyroidism | Abstract similar documents |
| N. G. Mokrysheva, Yu. A. Krupinova, E. E. Bibik, G. A. Melnichenko | ||
| "... Cognitive impairment (CI) is a nonclassical manifestation of primary hyperparathyroidism ..." | ||
| Vol 10, No 1 (2018) | Cognitive impairment in anxiety disorders | Abstract similar documents |
| B. A. Volel, D. S. Petelin, R. V. Akhapkin, A. A. Malyutina | ||
| "... . Cognitive impairment (CI) is one of the most intensively studied aspects of pathological anxiety ..." | ||
| Vol 9, No 1 (2017) | Cognitive impairment in diabetes mellitus | Abstract similar documents |
| V. B. Sosina, V. V. Zakharov, I. A. Strokov, N. V. Vakhnina | ||
| "... , and clinical features of cognitive impairment (CI) in diabetes mellitus (DM). It presents the results ..." | ||
| Vol 6, No 4 (2014) | Cognitive impairments in cerebrovascular disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... Cerebrovascular diseases belong to a group of the major causes of cognitive impairments ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
| D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
| "... Objective: to compare a multimodal drug approach to treating poststroke cognitive impairments (CI ..." | ||
| Vol 13, No 3 (2021) | Severity and treatment of cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, V. V. Zakharov | ||
| "... With an increase in life expectancy in the population, the proportion of people with cognitive ..." | ||
| Vol 4, No 1 (2012) | Higher psychic dysfunctions in adult patients with epilepsy: role of antiepileptic therapy | Abstract similar documents |
| Kira Vladimirovna Voronkova, O A Pylayeva, I A Buchneva, T M Akhmedov | ||
| Vol 14, No 4 (2022) | Cognitive dysfunction in patients with Chiari malformation type 1 and its relationship with the degree of cerebellar tonsil ectopia | Abstract similar documents |
| R. G. Kokurkina, E. G. Mendelevich | ||
| "... State Examination (MMSE), the Montreal Cognitive Assessment (MoCA) and the Trail Making Test (TMT ..." | ||
| Vol 1, No 1 (2009) | MEDICAL INFORMATION IN THE STRUCTURE OF COGNITIVE THERAPY FOR PANIC DISORDER | Abstract similar documents |
| A. M. Burno | ||
| "... The paper describes the procedure of cognitive therapy for panic disorder, which is based ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... Cognitive Assessment (MoCA); the Hamilton Anxiety Rating Scale (HARS); asthenia rating scales ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Non-drug therapies for cognitive impairment | Abstract similar documents |
| I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova | ||
| "... The review considers basic methods for non-drug correction of cognitive disorders, as well ..." | ||
| Vol 13, No 4 (2021) | Influence of genetic and comorbid emotional-affective factors on pre-mild cognitive decline in middle-aged patients | Abstract similar documents |
| N. N. Koberskaya, T. M. Ostroumova, V. A. Perepelov, D. S. Smirnov | ||
| "... Recently, maximum attention has been drawn to the earliest forms of cognitive deficit - pre-mild ..." | ||
| Vol 7, No 1 (2015) | Cognitive impairments in cerebrovascular disease: What is between health and dementia? | Abstract similar documents |
| A. Yu. Emelin | ||
| "... prevalence of both acute and chronic forms of cerebrovascular diseases (CVD). Cognitive dysfunctions ..." | ||
| Vol 12, No 5 (2020) | The possibilities of diagnosing and treating cognitive impairment at non-dementia stages | Abstract similar documents |
| A. Yu. Emelin | ||
| "... detection and treatment of nervous system diseases accompanied by impaired cognitive functions is one ..." | ||
| Vol 10, No 2 (2018) | Effects of some commonly used drugs on cognitive functions | Abstract similar documents |
| O. D. Ostroumova, E. V. Shikh, E. V. Rebrova, A. G. Abrosimov | ||
| "... The paper discusses the effects of drugs from different pharmacological groups on cognitive ..." | ||
| Vol 9, No 2 (2017) | Cognitive impairment without dementia: A current view of the problem | Abstract similar documents |
| Yu. A. Starchina | ||
| "... In recent decades, special attention is given to cognitive impairments (CIs) without dementia ..." | ||
| 1 - 70 of 422 Items | 1 2 3 4 5 6 7 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
